missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Description
BCMA/TNFRSF17 protein is fully biologically active when compared to standard. The ED50 as determined by its ability to inhibit APRIL-mediated proliferation of anti-IgM stimulated murine B cells is no less than 40 ng/mL, corresponding to a specific activity of >2.5 x 10^4 IU/mg in the presence of 100 ng/mL human APRIL.
Specifications
Specifications
| Accession Number | Q02223, Q02223, Q02223 |
| Concentration | LYOPH |
| For Use With (Application) | PAGE, Bioactivity |
| Formulation | Lyophilized from a 0.2 um filtered concentrated solution in 30 % acetonitrile, 0.1 % TFA. |
| Gene ID (Entrez) | 608 |
| Molecular Weight (g/mol) | 5.4 kDa |
| Quantity | 100 μg |
| Storage Requirements | Store at -20°C to -70°C as supplied. After reconstitution, store at 2°C to 8°C for 1 month and at -20°C to -70°C for long term storage. Avoid repeated freeze-thaw cycles. |
| Endotoxin Concentration | Less than 1 EU/ug of BCMA/TNFRSF17 as determined by LAL method. |
| Gene Alias | B cell maturation antigen, B-cell maturation protein, BCMA/TNFRSF17, BCMAtumor necrosis factor receptor superfamily member 17, BCMB-cell maturation factor, CD269, CD269 antigen, tumor necrosis factor receptor superfamily, member 17 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?